跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 162 条关于
“SNIPRx-surf”
全部
162
临床试验
96
药物
30
机构
12
资讯
24
去年
Repare Therapeutics Licenses Discovery Platforms to DCx Biotherapeutics in Strategic Refocus on Clinical Pipeline
去年
Surf Bio Strengthens Leadership Team with CMC Expert Doug Hecker to Advance Subcutaneous Biologic Delivery Platform
上个月
Halozyme Appoints Dannielle Appelhans to its Board of Directors
去年
Stanford Research Demonstrates Ultra-High Concentration Biologic Delivery via Subcutaneous Injection
3年前
Repare Therapeutics' ATR Inhibitor Camonsertib Shows Promise in DNA Repair-Deficient Cancers
去年
Repare Therapeutics to Present Phase 1 MYTHIC Trial Data of Lunresertib and Camonsertib Combination in Advanced Cancers
去年
Phase 1 Trial Launches to Evaluate TYRA-300 in FGFR3-Mutated Urothelial Cancer
2年前
Camonsertib Shows Promise in ATM-Deficient Advanced Solid Tumors
去年
Tyra Biosciences Stock Target Adjusted Following Clinical Data Review
去年
Repare Therapeutics Initiates Phase I Trial of RP-3467 for Advanced Solid Tumors
第 1 页,共 3 页
上一页
下一页